Mad Money w/ Jim Cramer 3/10/26

0:00Hiring isn't just filling a role. It's about finding people who can drive results. Indeed, sponsor jobs helps you match with the right candidates faster. Target candidates by skills, certifications, or location. Join the 3.3 million employers worldwide that use Indeed to connect with quality talent that fits their needs. And listeners of this show will get a $75 sponsor job credit to help get your job the premium status it deserves. And indeed.com slash podcast, terms and conditions Hiring to it the right way with Indeed. Before we had AT&T business wireless coverage, our delivery GPS wasn't the most reliable. Once our driver had to do a 14 point turn to get back on route, a 14 point turn and influencer even live streamed the whole thing. Not good for business. Now with AT&T business wireless, routes are updating on the fly and deliveries are on time. And the influencer did get us 53 new followers though. AT&T business wireless, connecting changes everything.

1:21Hey, I'm Kramer. Welcome to Mad Money. Welcome to Kramer. Other people are like friends. Hey, I'm just trying to make a little bit of money here. My job is not just to entertain but to educate and do some teaching. So call me at 1-800-743-CBC or tweet me at Jim Kramer. See these hands? You know what? It's the best thing you can do with them in this market. I'll show you. Sit on them. That's what? Because if you're buying and selling stocks to this very moment instead of sitting on your hands, you're going to drive yourself crazy. You're going to make mistakes and you'll end up looking like a fool because the backdrop is pure lunacy. It's very hard to make money in this kind of environment even on what looked like a plastic day where the Dow did 34 points, the S&P Edge down point 21% and the Nasdaq actually advanced point 0.1%. In truth, it was anything but plastic. But I don't want to get ahead of the story. Every day I do this 10-minute morning meeting for CNBC's investing club members with my partner,

2:22Jeff Marx, starts at 10-20. We stream it, always ends at 10-30. Or at least I try to get it at 10-30. Sometimes I'm bursted with an idea so I refuse to stop. Today I told the story of the misery of the hedge fund manager and the ecstasy of the individual investor because that captures a lot of what's going on right here right now. Sure look like we were going to have an easy day. The market seems soggy this morning. We'll hang out at around $90 up to 10. There's tough to read. But then at eight o'clock, Secretary of Defense Hegs-Hegsuth went on the work path talking into cadence that indicated things were about to heat up big time. He said that today would be quote, the most intense day of strikes inside Iran. He was going to launch in his words, the most fighters, the most bombers, the most, well, I mean, just keeps going on strikes. Yeah, what do you remind him, man? He reminded me of the general in 12 o'clock high, oh, so many years ago, telling the young fliers, the message of the air that they were going after the plesty oil fields from Romania just to disable the third right once and for all. Or perhaps

3:24this would be the like, like the beginning of big week, where our planes darkened the skies, bombing all sorts of German facilities, including a keyboard bearing manufacturing plant for full week, February 20th to February 25th, 1944. Germany was still a target-riching bombing. Then Hegs was switched to Channel Captain John Paul Jones, saying we'd only just begun to fight. Jesus, what would be doing these last 10 days? Then he finished with a quote from a Psalm, different. One thing for certain though, Hegs-Hegs clearly didn't get President Trump's memo yesterday that the war is almost over. So you'd think that stocks would get carbon, right? Because he's going to boil up the oil market. We know that if oil goes higher, stocks go lower. If we're going to do daylight precision bombing to take out Iranians leaders, or nighttime saturation bombing to question facilities, you can bet that oil will be ready to soar after yesterday's pullback. If you run the hedge fund, you know what you do? You heard that speech. You would short the entire stock market. Hegs is handled like the kiss of death for stocks.

4:25I know I would, if I were still running Cramer Company. Yep, what happened? Turns out you were in into a buzz saw. Center on the data center, no less. Some of the disembing doctors that go into the data center, I'm talking about Cgate, Western Digital, San Francisco, Micron, why those? Because the CEO of U of Packard Enterprise said last night on his conference call that there would be no lead up in the memory shortage that's allowing these companies to practically print money. Couldn't last a long time. Now if you're a hedge fund manager who bet against this market this morning because of what Hegs-Hegs said, especially you bet against tech, you can't handle the kind of losses you were racking up in the morning. Maybe the short sellers could have held on for a couple more hours because the interest rates were going lower. Always be up for stocks. But when oil reversed from a short flip up and started to go down, and I'm talking about really down, down hard. The bears lost the crop. They needed it. Instead they got their lungs ripped out. It gets tougher for the bears as the day went on. A social media post plan up under the energy secretary Chris Wright's name that a US Navy destroyer shepherded an oil tanker through the straight of her moves. If that's true, then it's game over to the bears. Why? Because Iran's been blockading

5:29a stretch of water and that's been wrecking the global economy. It was practically the best sentence for the short sellers. Can't fight oil going lower. Can't fight the tap going higher. Can't fight the Navy crushing the Iran's fleet. You had to expect a monster move higher. The tape ruled. Any hedge fund manager who was still short probably covered with that long. Then CMBC comes out around the peak of the run and says that the tweet was just deleted. Huh? Just like that. There was no tag or there was no convoy. So of course oil starts creeping right back up and the market stops going higher. In fact, it turns around. It gets worse. Forget convoy. People in Iran might be mining the street. Still oil goes right back up and finishes down. Instead of being down 15% is down only 9% and the stock gains disappear. Remember this is not long after the convoy tweet caused most of the shorts to throw in the towel. Do they go back in knowing the big week is starting that the Iranians are all about fueling the lash or do they just do nothing because who knows what the heck is going to happen now. Incredible. The hedge fund manager

6:31had started short and doubled down on the Secretary of the right bogus tweet about the Navy protecting the tanker. She would have made a killing. Crushed it. And that's despite the fact that oil went down 12% one of the worst days for petroleum and history. So much for my oil goes lower stock go higher. You know it's tough. I know that on a day like today clients at my old hedge fund would have been expected me to make money. When you can go up and down that's their bottom for hedge fund managers. They have to play. If I were in that position I'd fuel the calls for my clients who wanted to know how much money they made after a crazy session to the dollar. Look I'm on a sky so I tell them the bad news that I got short when oil looked like them went higher and I covered it high. You lost. That's what I'd say. You lost money. Of course my first idea to go short actually turned out to be the right idea but for no particular reason other than we await tonight's target list. Long story short this kind of session is poised into hedge fund managers because they feel compelled to take action with days like today. Oh and after the bell Oracle posted a good number. I'm sure the hedges we fly it in take it take the stock up this morning

7:33and then short it tomorrow. It's going to start all over again. But what about regular individual investors. If you're managing your own money there's a simple way to handle today's craziness. You do nothing. Why? I think it should be obvious that this kind of action is not conducive to anything. Sure last night HPN Impression Report we talked about how memory chips remain in short supply. You might have wanted to join the scrum going for the memory chips but by the way they roll up before the market open. It's much better to do nothing people. You don't have clients breathing down your neck expecting you to make the money every day. You can sit on your hands when the situation is this unclear. Of course it's not an easy thing to do. In your old day people got buying this and selling that heatless of the tax consequences. You're probably joins in just to pull the trigger right or I can tell you this is just not worth it. You have no gun to your head and that's your edge. Do you really want to worry about cabinet level social media posts or the fire and brimstone rhetoric from the Secretary of Defense? I sure don't because nobody's

8:38looking over your shoulder. You don't have to parse this stuff. It's a pleasure to not be worried about how you missed the lamb research move or shorten your applied materials and head your head handed to. I say rejoice. The bottom line this moment's full of surprises both positive and negative in that order which means when you buy you have to have you have to brave a level of turbulence that only President Trump too. Not the first one. The second could possibly spawn. The only thing you can reasonably expect here is more chaos. So make your peace with that and stop trying to trade your way to riches. They'll trade your way to the poor house. Invest. Don't trade. Pick good stocks. Hold on to them. Buy an index fund right next to it and play the long game. Jim and Wyoming who's Jim. Thank you Jim for taking my call. Of course. What's happening? Well, thanks for your work and so hard on giving us such excellent advice. I've benefited. My family's benefited from your advice. Oh, thank you. Thank you.

9:39Thank you. Thank you. Long time listener since the days of Kylo and Kramer. Man, let's go back 26 years, right? It's a mere fantastic. Yeah. So I called you a while back when PayPal was around 68 and asked you for your views and you said you thought Capital One Financial was was a better stock and your advice was excellent. Thank you. PayPal is now around 45 and two events happened on March 1st. Number one, I became 90, the big 90. But more importantly, in Ricky Loris who's been the CEO of Hewlett Packard has been doing a terrific job there. A resigned from Hewlett Packard and became the CEO of PayPal. And he's also been a board chair of PayPal for the last couple of years. So he's very familiar with his challenges and opportunities. And I wondered whether that changes your view in any way on PayPal. Well, you know, first of all, congratulations to be 90. I will tell you, sir, that I think PayPal is a hard stock,

10:40a hard company to fix. It's been this price journey is multiple has been going down, down, down, because frankly, it's just not that good accompanying. And I don't know if Enrique can fix it. And that's the problem. I'm sorry. Let's go to Jerry and Missouri. Jerry. Hey, Jim. Thanks for taking my call. All right. The light of you on the show. How can I help? Jim, last summer, you recommended this company. I bought a position. The annualist liked it. You wrote about it in your book. It went way up. But now it's way down. Over 50% from the sold-time highs. It's a wild trader. Do you still like Reddit? Very much. I was surprised. I was telling my colleague Ben Stoley, as I said, if you see where Reddit's going down, that's not Steve Huffman's doing a really good job. It's a terrific product. Everybody I know has their own site that they constantly check on. And I think that Reddit is a solid buy in Huffman order. Come on. He's doing a terrific job. All right. Listen to me,

11:41the only reasonable thing that you can expect right now with this tape is chaos. That's why it's okay to do this. Don't feel bad about it. Just don't make any big market decisions. There's no gun to your head. Sit on your hands. All right, everybody. Tonight, yesterday 500 is getting some new members as a couple of weeks. As part of its regular reshuffing. I'm sitting down with one of them. Don't miss my exclusive with a really great company called Go Hearing. Then Metronix finally completed his spin-off on Steve Beauty's business. So where's the stock stand now without that? I'm taking the pulse of the coming. And here's one that we've liked since the team, Celsius, shot up after earnings. We went to fall alongside the rest of the December stocks over the past week. I'm getting the full store from the company's top rest and I bet you don't like what I hear. So stay with Kramer. Don't miss a second of Mad Money. Follow at Jim Kramer on X. Have a question. Tweet Kramer.

12:44Hashtag Mad Mentions. Send Jim an email to madmoneyatcnbc.com or give us a call at 1-800-743-CNBC. Listen up. True Trade has revolutionized the trading industry with its AI-driven technology. This isn't hype. This isn't theory. This is a smarter, modern way to engage the financial markets. True Trade puts institutional-grade trading technology in the hands of everyday Americans. Tools once reserved for the wealthy. No need to know what or when to trade. No trading experience doesn't matter. You purchase the platform, connect your trading account, download the mobile app, and turn it on. It's that simple. And if that's not exciting enough, True Trade assists their clients in accessing tens of thousands of dollars in tradable funds, giving you the ability to participate without risking your capital. Join thousands worldwide who are already benefiting from True Trade's trading technology. Visit truetrade.io. That's TRU-TRADE.io. True Trade, where technology earns for you.

13:51Trading involves risk, including the possible loss of principle. See terms and conditions. United Health Group is simplifying healthcare by investing in tools to help patients know more and pay less. These tools help patients find providers and compare costs and save hundreds of dollars annually. Learn more at unitedhealthgroup.com slash commitment. Not every sale happens at the register. Before AT&T Business Wireless, checking out customers under mobile POS systems took too long. Basically a staring contest where everyone loses. It's crazy what people say during an awkward silence. Now transactions are done before the silence takes hold. That means I can focus on the task at hand and make an extra sale at two. Sometimes I do miss the bonding time. Sometimes. AT&T Business Wireless, connecting changes everything. Last time I mentioned the four new stocks that are joining the SP 500 later this month,

14:52including CoHearton. That's an optical networking play with a stock that's up more than 40 percent. You're the date. This thing's been red hot because it's a data center play. We're talking about clusters full of advanced ships and they only need to connect to each other. The most efficient way to do that is with optical equipment, including the hardware from CoHearton. When these guys reported their most recent quarter in early February, they blew away the numbers with bookings extending well into next year. Then just last week, Nvidia cemented the story. They're investing two billion dollars into CoHearton as part of a broader push into advanced optical technologies. Now look, my only fear is this one's come up too far too fast. But then again, there could be a multi-year move ahead for them. So let's take a close look with Jim Anderson. Old hand, CEO of CoHearton. Mr. Anderson, welcome to my money. Thank you, Jim. Thanks for having me. All right, so Jim, all right, we've got to do CoHeart101 because I think a lot of people say, okay, there's just too many data center, eyes closed over and they can't let that happen. We're not a household name. So Jim, you can think about CoHearton as we're a global leader in photonics. And what photonics

15:57is, so you mentioned the data center. In the data center, what photonics is all about is it's really simple. It's about transmitting information using light. And so that's everything that we do in data center summed up. And we can't use copper. Does it fast enough? It's not. You can, but in the data center, here's why you see more and more of the connections being made using light. And the reason is is because there's tremendous growth of the amount of data flowing through these data centers. And as you crank up the data rate and you crank up the bandwidth, as you're trying to transmit more and more information, the most power efficient, fastest way to transmit that data is using light. And so what we've seen is a move away from copper towards optical photonic connections over time. And that, and that transformation continues. Now it has, is that what brought Nvidia to invest in you? Yeah, so that's exactly right. So our partnership with Nvidia is around continuing to innovate on new data center architectures. But really what we're bringing to the table is that photonics expertise. It's that expertise of

17:01how do you transmit information at super high bandwidth using light, which is very power efficient. And so that's what we're bringing to the table in that Nvidia part. They also gave a $2 billion investment. I guess what you have to consider competitors, right? Really, we consider them a partner there. Actually, yeah, they're actually a customer of ours and they're a supplier to us. So I wouldn't call it co-op. Co-op investors in that data center. It's a complicated world, right? So, and I think look, I think the investment is good for both companies. I think both companies will do well. I think when you look at coherent, we're really pleased with not just the $2 billion investment, but we were especially pleased with the long-term supply agreement, right? So the long-term supply agreement with Nvidia, it stretches out to the end of the decade. It's multiple products and it's multi-billion dollar. And so that is a step function expansion in our partnership with Nvidia. Nvidia has been a customer of ours for over 20

18:03years. So this is a big expansion of that partnership. Well, I'm going to ask you something. I've been out front saying that when Nvidia gives money, invest money, that's because Nvidia wants to make money and wants to have a great relationship. And there's all these people who are very critical and say, no, that's Nvidia giving money to Jim and he's giving it back because you was playing to people how wrong that is. That is wrong. What Nvidia has done is they've invested $2 billion in coherence there. And they bought stock. And they bought stock. And so now they're a shareholder. They're one of my larger shareholders in the company. But on the second part of the agreement, the partnership is they're now going to be buying product from coherent, right? So that's a supply agreement. And what's good for Nvidia is they get that security of supply, right? So it's really good for both companies. And that really matters because there are certain things that are particular to you. Indian Fossified. Now, I've got to tell you, I'm not a pretender. I don't know what that is, other than that it's hard to get and hard to deal with. But you guys have an expertise. Yeah, we've been making Indian Fossified products for over 20

19:07years. And Indian Fossified is really the key material that goes into the lasers, which create the light in the fiber optic cables of the data center network, right? So it's basically the light source. Very difficult to design and manufacture at high quality levels. So we're one of the very few companies that have this capability. And so this was one of the key, the key things that we were bringing to the Nvidia partnership. Now it's more than that. They're using more than just our lasers. We have a broad range of products. But that's definitely a key capability. And this is something that we've been investing heavily. If you look at our Indian Fossified capacity, we're doubling that year over year. And we're building the world's, we have the world's most advanced production facility. And where's that? And that's Sherman Texas. That's the location. Isn't that so? And Jim, this factors into the partnership as well. Because Nvidia loved the fact that it was US manufacturing. So they're investing in US manufacturing. That's a great facility. It's leading the industry with the first six inch Indian Fossified production.

20:08And we're investing in growing the capacity. So Jim, why do people say that we can't make stuff that has to be in Taiwan that we don't have the engineers? I mean, here you are. Sherman Texas is a miracle. That is absolutely true. Look, we were founded as a US manufacturing company over 50 years ago. We were founded in Saxonburg, Pennsylvania. We still have a list of all that. You've got a list of Saxoners. That's our headquarters. But we have over 20 manufacturing facilities in the US across 13 different states. And we are investing. We're investing in US manufacturing. And some of the most critical technology that we deliver to the data center, to the telecom network, to industrial applications is made right here in the US. So tell me, just beyond the data center, there are other things you guys do. I mean, we've spoken with data center, but you have other businesses that are really good. And we love the other businesses. It's just, we hardly ever get asked about them. But the other businesses are telecommunications. So we make all sorts of optical components. I think that's because we know

21:09from corning. That's exactly the great company corning, right? So another big part of our business is industrial. So that's about 30% of our revenue. So we make industrial lasers. So we use photonics for lasers. I used to make fun of that because I always said it was like bond. You're finished. So I said, oh my god, it seems like a bold figure. I agree. But industrial lasers get used in all sorts of applications, James Bond movies, but also medical applications, semi-cap equipment. Actually, that's where we're starting to see some growth pickup is lasers are used at all in all over the manufacturing for semiconductors. And so we're seeing nice pickup and growth there. So yeah, really broad range of business. It's just, it's a very good story. Obviously, it's moved up a lot, but if things go your way, obviously this is, once you get things rolling in your industry, like Lisa Sue, the three, six, or of course, Jensen, it doesn't stop. People can think it has to stop. But not if business is good. Well, look, I think the company has never been this well positioned

22:11as it is today. Totally agree. Okay, that's Jim Anderson from Coherent. Now, you got a COHR. They do have lots of stuff to learn about, but I want you to, if you're going to buy it, try your best. I've tried and I'm making some headway and I want to thank Jim for making it so that it's more accessible. Everyone is back here for the break. Coming up with Medronics spinning off part of its company is now the time to buy into the medical tech giant. Kramer is making his diagnosis maxed. United Health Group is bringing in-home treatment directly to patients, closing caregabs, identifying risks earlier and improving patient outcomes. In 2025, patients received over 19 million home visits. Learn more at UnitedHealthgroup.com slash commitment. Bringing your business dreams to life takes heart and about a thousand decisions a day. That's why Atlantic Union Bank's knowledgeable bankers are here for you. With the right guidance and customized solutions to help you reach your business goals. So whether you're planning your next move,

23:11upgrading your space or scaling to meet demand, we make sure your business is ready for what's ahead because we are big enough to support you. It's small enough to know you. Atlantic Union Bank. Anyway, you bank. Thy ticket, Lady Jennifer of Coons. Well, many thanks. Good, sir. Here is my discover card. They accept a discover at Renaissance Fairs? Yeah, they do here. Discoverers accepted at the places I'd love to shop. Get it with the times. With the times. You're playing the loot. Yeah, and it sounds pretty good, right? Discoverers accepted at 99% of places that take credit cards nationwide based on the February 2025 Nilsen report. We spent the last week and a half focused on the war with Iran. And rightly so, but that means you may have overlooked some great individual stock stories. Even when the global economy is in chaos, I think it's worth trying to pick potential

24:15long-term winners, which brings me to Metronik. Late last week, this medical device titan spun off its diabetes business as mini-med, which began trading separately on Friday. Now, you know I love a good corporate breakup story. This is a terrific way for big businesses to unlock value because Wall Street generally prefers smaller and more bite-sized investments. Plus, the diabetes business has gotten pretty challenging thanks to the rise of GLB-1s. So, spinning this off makes, I think, the old Metronik much more enticing. Even a decade ago, when the standard of care for diabetes was continuous blood sugar monitors, this was a fiercely competitive space with avid labs and dexcom running circles around Metronik. That's when they came up with some serviceable options, but by then it hardly mattered because that's when the GLB-1s came along. Like Novonur, Sozampik, and Eli Lelizman-Jaro. These injections can help manage type 2 diabetes that will also help you lose weight. Now, even before the GLB-1s, Metronik, the type of diabetes division, has been flat and negative in growth, safe from fiscal 2020 through

25:21fiscal 2023. It's one reason the stock piqued the September of 2021, and then lost nearly 50% of its values of plummet to its lows on October of 2023. In fairness to Metronik's diabetes business, it's been doing better in recent years, posting much better growth numbers, and the stock's done better too, even if it's been stuck in a rut for the last 12 months. I'm thinking this is going to jar it out of the rut. Still, I think the diabetes unit was weighing on Metronik. Just look at how hard it was for these guys to sell the market on Mini-Man. Originally, when the IPO Roadshow started two weeks ago, they were looking to sell 28 million shares of Mini-Man at $25 to $28 a share. In the end, they were able to sell at 28 million shares. Oh man, they had the price of the $20 to get the deal out the door. They don't fry at Mini-Man open down in 1905. Yeah, and it kept getting covered. Yes, they had finished the session at $18.20. It was going too high. Today, it made about me better 1.8%. But you know, there's clearly not a lot of enthusiasm for this one. Of course, last week would have been a bad time to price at any IPO, but Metronik was clearly determined to make this Mini-Man offering

26:23happen as soon as possible. And if we're clear, Metronik's not quite done with the business yet. See, Metronik still owns 90% of Mini-Man. They said they'd just plan and distribute these shares to shareholders by the end of the year. Hey, by the way, that's why Metronik kept getting hit at the Mini-Man IPO. Every time Mini-Man goes lower, Metronik stock is worth less, too, until they finally do the distribution. Needless to say, I'm not interested in Mini-Man at all. Thanks to the Ghibli's S1s, diabetes, no longer growth business. But I absolutely think that a slimmed down Metronik, well, that could be worse something with the spin-off of the diabetes division. Metronik can now focus on its three remaining business, cardio vascular, neuroscience, and medical surgical. All these businesses are much larger than the diabetes division was, vast total addressable markets. They're growing either high single digits or mid-single digits. I'd like that mid-single to go higher, but bear with me here. Let's take these units, my boy. Cardiovascular division, which is the largest division and the one that's doing best right now. After posting 6.3% organic growth in fiscal year 2025, which ended in April last year,

27:28the cardio business posted organic growth of 7%, 9.3% and 10.6% in the last three quarters, going in the right direction. In other words, Metronik's largest business here has been accelerated revenue growth, ARG, ARG, even as a mature business. That's fueled by the strength of their cardiac rhythm and heart failure subdivision, which had 17% organic growth in the most recent quarter. They have terrific technology for minimally invasive heart procedures. Metronik is real leadership here, which is why every part of the cardio vascular business is in growth mode. Peripheral peripheral vascular health is up high single digits, cardiac rhythm management, cardiac surgery and coronary and renal denervation are up mid-single digits. Structural heart is the laggard of the cardio unit, but even that was up low single digits in the latest quarter. Metronik's next large division is the one bothers me because I think you can do much better than neuroscience. At a 5.2% organic growth in fiscal 2020, it's been decelerating in the growth rate this year, from 2.5% to 4% growth in each of the last three quarters. I don't like that.

28:28There's still some areas of strength here, cranial and spinal technologies, growing in a 9% clip in the United States with core spine business, amidst single digits. In February, Metronik was also the FDA approval for a new product, an AI-driven platform that helps perform robot assistance spinal surgeries. My hope is that with many may go on, maybe they can focus on making the neuroscience division much stronger. That can be a very fast growing business. Finally, there's the medical surgical unit. This probably has the most upside. This business has flat as growth in fiscal 2025, but it's done a bit better of late averaging 2.1% organic growth through the last three quarters. Here at Metronik's endoscopy business, this is up 10% in the most recent quarter, with their acute care monitoring unit putting up high single digit unit growth, and I was thinking of getting growth. While the surgery subsequent has been holding back, this division is over all numbers. Their UGO robotic assisted surgery just had its first installation in the United States last month. Over time, that platform could turn things around. I think that could be a huge business and be like intuitive surgical. That's how good it can be.

29:29Now, take a step back. I like Metronik because the company is solid growth. It's extremely problem. If you're worried about a rant or peter in the global economy, well, this seems recession-proof. For their fiscal 2026, which ends next month, Metronik's expected to put up nearly 5% organic growth, as well as 5.6% earnings growth. But for next year, Metronik's already guiding for accelerating revenue growth and high single digit earnings growth. I think that kind of growth profile could attract lots of investors in this newly volatile environment. Same time, look, stocks cheap. It's trading at 16 times this year's earnings estimates less than 15 times next year's numbers. That's way low. And that would be yield 3.2 percent in the current level. This is a really good story. Here's the bottom line. Now that Metronik has taken their diabetes division public and plans to distribute their many shares to its investors sometime this year, I have much more bullish on this stock than I have been in ages. With diabetes going, Metronik can focus on its already solid core businesses. At these levels, I think the stock is simply too cheap to ignore. In a different kind of market, I might be hesitant to recommend this one. But we're definitely looking at economic slowdown because of the war with

30:32the ran higher gasoline prices. If not an outright recession. That's the kind of backdrop where the medical device stocks tend to become irresistible to Wall Street. I want to take some calls. Let's go to Carter in Tennessee. Carter. Jim, with the Medicare Advantage rates about three get renegotiated here in a couple weeks, do you think now is a good time to start a position in UNH? Well, look, I'm not going to analogize directly because I know there are different companies. But when I saw what happened to Centine, which you know is a very good company today, it just took my breath away, sentine down $7. I'm just afraid that this thing is just too topsy-turvy. Could that happen in the United Health? Look, when you're in Medicare and Medicaid, the answer is yes. And that does worry me. I'm going to say no to UNH. Even though they've got that great optimization, do so many good things. I don't want to touch it. Let's go to Dave in Texas, Dave. Yes. How are you, Jim? I am good, Dave. How are you doing? All right. The reason I called is Berkshire Hathaway. I noticed that they don't seem to be participating in the recent rally relative

31:40to oil stock. Yet they have a huge investment in accidental petroleum and a substantial investment in Chevron. Are people missing that? I think that they're trying to get their arms around the fact that Warren Buffett is no longer running. And I have to tell you, I think it's a good company, but there was a Warren Buffett premium in it that is now gone. And that's what's happening, even though you're absolutely right. They have also good pipelines. It just doesn't seem to matter to this market. Now, I'm more bullish on Medtronic than I have been in ages. I think at these levels, it's become too cheap to endure. Much more man-made money ahead and clean my exclusive with Celsius. What's ahead for the energy drink maker in turbulent space for consumer stocks? I'm hearing from the CEO, Ben. I have a suggestion for the private credit companies if their loans are as good as they say they are. I'm telling you what it is. And all right, of course, rabbit finds the nicest of the lightning round. So stay with Creeper.

32:46We recently got this terrific quarter from Celsius Holdings. The energy drink maker was to put a 170 percent sales growth huge earnings speed in response to stock jump just to finally 7 percent. And that was on top of a 74 percent gain last year. But this was before the war with the ram broke out causing the energy prices to surge, which in turn crushed all sorts of consumer stocks. Celsius included. Stock fell 20 percent last week. In other words, I think you're getting that spectacular quarter for free now. Could this be the buying opportunity we've been looking for? Let's check in with John Fieldy. He's the well-caffeinated chairman, CEO of Celsius always applied up. Mr. Fieldy, welcome back to my buddy. Glad to be here. It's just bringing the energy. Well, I want you to bring that. But before we get started and talking about where you guys are, I want to know. And it's important, John, are we now set with the relationship with PepsiCo? No more changes. We're like, we know exactly the moving parts are finished. Yeah, Jim. I mean, when you let coming off the heels of 2025, we've really re-structured this organization our portfolio. We went from a singular brand

33:47since last time we were here to a portfolio of mega brands. We'll dive into that with Celsius, Alani, and Rockstar. And we're the category captain of the energy category for Pepsi. That further in strengthens our capabilities. We're strategically tied in, managing priority periods, and we're leveraging them for the best in class distribution and execution out there. So we further enhanced this and also the capabilities in the organization. I am struck by what you've done with Alani knew. I mean, whether it be a cherry bomb, which I guess is done, we can't even get it, cherry bomb. Or whether it's the growth that you've been able to turbocharge here. What made this thing become the juggernaut in the industry? Yeah, it's phenomenal. We transitioned over to the Pepsi distribution network, December 1st with Alani, brought in cherry bomb, and now we're launching lime slush right now in retailers. Jim, we're expanding the category. Look at this powerhouse portfolio. Celsius fitness lifestyle brand. We're bringing incrementality, male, female, 50, 50. You've got Alani, a female focused brand that's inviting an approachable with really fun

34:49and great flavors and profiles. So we're really capturing a new segment, new consumer within the energy category. And females are coming into the category more than ever before and increasing their consumption. And we're really capturing it with our total portfolio approach. Well, it sounds like the family of brands is now popular at Walmart at Target at $7.11 in dollar general. What kind of shell space are you getting? We're excited this year. We're getting anticipate 17% growth in Celsius. That's more space gains. And Alani is going to get over 100% distribution gains this year. We're right in the middle of reset. So resets are starting. They'll take place towards the end of spring. By the time getting to summer will be fully reset. But we're expected to get a lot of distribution gains here, which we're excited about. And also, the biggest opportunity is the convenience channel. And both Celsius and Alani have been outgrowing the category growth rate and convenience, which is still 60% of the energy during category. How about a rock star? I bet you you can energize that. I mean, that's a big convenience store. We always see it there. And yet, I was surprised how little growth that has right now. John

35:50Philly has not come. It's not been able to get that one going yet, Hazy. We're just getting started with it. We have some great marketing. We know that how to connect with consumers in a cultural way and an emotional way. We're going to bring back rock star. Lots of opportunities there. That's that core male consumer, which you look at Celsius and Alani. Really hasn't really resonated well. But that's the big opportunity. So we're 50% of the category as well. And it goes ahead to head with some of those larger brands in the category. You know, John, I've been thinking you're the first person that has come out at my restaurant that I used to own. We went from being a cocktail place to being a mocktail place. 55th. You're the first person to come out and say, you know what mocktails are for real and they're growing that they're not just a passing phase, right? Yeah. What we're seeing in the energy category over 30% of consumers that are consuming energy drinks in social occasions. And we know what's happening with beer and liquor sales. They're supplementing that. Energy is perfect for it. And our portfolio is perfect for it. When you look at right here, I have a pink lemonade ready for

36:51summer. We have talked about some of the other cherry bond flavors. We have dirty Alani flavors and mocktails written up that are doing extremely well in bars and restaurants as consumers are looking for alternative choices and spanning social occasions. We're also seeing consumption of energy drinks and with meals, breakfast and at lunch. So really seeing really the energies becoming part daily lifestyle daily routine, which we've talked about on several times last time we're on the show. So we're capitalizing on that as more occasions are coming within this category. Well, we use triggers of your product and our office and I found out that some of us like fizz-free. I don't know what that would possibly be like, but apparently it's okay. That's phenomenal. That's our big push this quarter with Celsius fizz-free getting ready for summer. That's a big segment within the energy category that's really been untapped and our Celsius fizz-free line tastes phenomenal and is really refreshing for this summer. So I want people to understand that this is the story I'm taking this phrase from you. More people, more polite places, more of it.

37:52More people, more places, more often. That's our core strategy. You look at the portfolio, you look at the distribution gains, you look at the consumption occasions, and then we're going global. We're taking over the world. This week we announced expansion in Spain. I had to team down in Australia kicking off the F1 inauguration in the first race of the year. We've expanded internationally. We're investing in resources as well and talent and capabilities within this organization and we're excited about this opportunity we see. Do any of the Alonni new people that they stay on? Because boy, I've got to tell you, they must be working well with you. They did. They have. We have a variety of those key partners and key strategic team members stayed on. Where we see synergies and opportunities is with our sales organization field marketing the back end as well. But we've taken a lot on as we further integrate. There's a lot of work here. We've been hired over 200 staff members in the first quarter of this year. So really excited. We're going big. We see the opportunity we're capitalizing. We're building the infrastructure

38:55and we're here to execute. Wow. I got to tell you what a break people are getting. Get a chance to get in after that amazing quarter. That's one of the best quarters of the year, John. Really was. The best quarter of the year. Phenom and year. Yeah. And year 2.5 billion in revenue, 620 in EBITDA. Phenomenal results all around. Couldn't agree more. I want to thank John Fieldley Chairman, CEO of Celsius Holdings. This is the right stock to own. If you're going to own the package, food company stocks. Thank you, John. Thank you. Cheers. We have my back here. Coming up, you've got questions. Claimers got the answers. Get charged up for a fast fire lightning round. Next. And then the lightning round is over. Are you ready? Keep going. Let's start with Chippen.

39:57Chippen is a Mississippi chip. Hey, Jim. How you doing, buddy? I'm doing well. How are you? I'm doing great. Hey, look, I'm up about 80% in EOG. I've had it for about four years. And I'm just trying to figure out if you think that's an own it. Don't try to stop. No, I think that it's still because it's honestly because it's oil and gas. You got a trim. I want you to sell half. I want you to sell half. I mean, you do that tomorrow. Sorry, Apple. Just I went, you know, I hit it a couple of times in his SOS time. You know, like, oh, here we go. So we got someone who's in the SOS world. Let's go to Craig and Cal Point to Craig. Hey, Jim, find it your thoughts on American Express, please. Yes, yes. Now, people are at the long lives out from market, especially since it's 303. It's all the way down from 387. And I'm going to tell you what I would do. Go against the sellers. I think the market's prices are great company. I would buy some right here and then leave some room by some $290 and then get longer if it gets a $280. That's the way I play it. Let's go ahead and then buy a J and about a J. Hey, Jim, how's it going? Not bad. How about you?

41:03Good. A long time club member. Excellent. Excellent. I ran into this stock last summer and picked up a half a position added to it in November. It's done pretty good for me. It's a infrastructure services play. It just got downgraded today. Unfortunately, a ticker symbol PR-I-M. Oh, that's a good company. Who would take, well, look, I think that someone might want to downgrade because there's up so much, but not be good, it's a bad company. I want you to stay low on that company. I think it's good. I want to go to Sam in Pennsylvania. Sam! Jim got an interesting one for you. This is a chemical company based in the Netherlands. We're looking at Mindel based though. The company's the lord's company. Oh my, what a home run right here because of polyethylene. You're going to go one on the unit two for on their throwing down. Those are the two that are working. I say, good move, sir. Let's go to Romeo and New Jersey.

42:05Romeo, where are we now? Hey, Jim, I'm panning about a golden nugget that you gave me last year's called PSIAC. Oh, we like that company. We like that engine. What the hell is that doing down? It's down. It's been cutting hair. That's crazy. They're doing very well. I have to call Ben Stodo and we're going to have to do a work-up on that one. I'm not letting that one just go one off like that. Let's do work. Okay, I need to go to Dave and Illinois. Dave! Dr. Kramer, congratulations later on in the week on completing your 20th season of Mad Money with Jim Kramer. And Dave, starting your 21st. There you go. Absolutely true. I'll have to change the graphic to be in the show. I'll get on that immediate. I do that too. I do it on my own at that. What's happening? Jim, this $20 billion came in island headquartered companies share space with Marvalle in high-speed Ethernet connectivity solutions for computers,

43:07servers, routers, and the like. Last December, you declared them a winner, but cautioned investors about customer concentration and insider trading. So, Jim, is Credo Technology Group still a winner? I think it is. I just like the other's better, Dave. And you know when I speak that way, you know that I like, there's like, you know, lots of stuff within the data center, including Marvalle that I think is better than Credo. But thank you so much. And yes, we're almost done with 20th. And that lays down the conclusion of the Lightning round! The Lightning round is sponsored by Charles Schwab. Coming up, as we wrap up another busy day, Kramer has some final thoughts. Don't miss his No Huddled. Maxed. You're as worried about these private credit firms as I am. You can now put your money where your mouth is. At least if you're a big customer of Goldman Sachs, they're putting

44:10together a product that lets you bet against baskets of private loans that are very similar to what these firms own. Now, this kind of product is very risky. Sure, you may look at these portfolios in these places and say, I can't believe they own that junk. But the situation is a little more fluid than you might think. I'm not saying that I'd be buying some blue alstock, but I am tempted by some blackstone. Because when they open the gates and where people want it out and expect it, employees put up their own money to meet their intentions. That's a real class act. I don't like private credit because I think your upside is pretty capped and your downside can be used if a company defaults. They're safe for places to get income. But betting against these funds? First of all, why would you ever bet against a pile of loans? What makes you think that their loans are all going to go bad? The prevailing wisdom says that these firms have loaned a lot of money to heavily indebted software companies that will be crushed by AI. The pessimists think it's so bad that it could do real damage to these private credit funds themselves. It might be a vicious cycle down for these bonds. When scared investors take every chance they can get to take their money out, sending the bonds still lower, maybe below what they're worth. It's not that easy, though.

45:11Let me give you an example of what Goldman Sachs might be shorting. Right now, some of these funds have issued loans to a company called Zendesk, which is an enterprise software company went private for $10.2 billion in 2022. Zendesk helped automate the call center and making employees more efficient. It would be natural to bet against Zendesk, right? Because AI can do it better. We all know that. You figure the bonds have to be trading down and either because of potential AI competition, or because who even need a call center software when AI makes these jobs redundant. But if you go to Zendesk site, you'll know that they've gone already all in AI. They didn't sit still. In fact, when I checked that 80s enterprise software companies are supposed to be dead meat, they too are adjusting rapidly in the new world. So it might not be easy to short. Keep in mind, shorting debt is much harder than shorting stock. Things need to go really bad before yes and the impact on the creditors. Still, if this paper is so terrific, why don't these private credit firms just sell some of it if they need to redeem in order to be able to please exiting shareholders? Why not raise cash if this stuff is as good as you claim? It would be worth it if the loans were sold even at discounted parts. In 1995, I have to tell you, I really don't

46:13understand why any of these firms are troubled if the loans are as good as they say they are. There's always a buyer at some price. My advice to these credit firms, you don't want anyone betting against you. Take action. When I had Lloyd Blankfine, former CEO of Goldman Sachs on the show to talk about his excellent new book, Streetwise, he was adamant that these firms should be selling slugs of bonds in order to demonstrate to the marketplace that the paper's good. Who else sold some of its loan that almost part or raised money to meet redemption? There was a novelty return cap of it. You see, it didn't impress Wall Street as the stocks kept coming down because the marketplace wants to see true redemptions, not some novel he paid back. In this difficult environment, you need to be able to meet redemptions from people who went out. That's plain and simple. That's how you demonstrate that your portfolio is a good one. The goal for a firm like Blankfine is to not get dead as Blankfine says in the book about a troubling period for investment houses. Selling some of these Zendest bonds and others like them would take the get dead off the table. I wouldn't advise shorting the portfolio of Bluel and that's among the highest risk of the firms. I wouldn't buy the stock of the company either. But if these portfolios are as good as Bluel says, then they can just sell some loans and

47:13meet the redemptions. Probably solve. Of course, if the loans aren't any good, well then all bets are off. But it's time for the Bluel to put their money where their mouth is themselves and prove the pessimists wrong. If they can't raise some money in their meet the redemptions, then I don't blame anyone for betting against them. Even I wouldn't take the risk myself. I'd like to say that you're always a bull market somewhere and I'd probably try to find it just for you right here on Mad Money. I'm Joe Kramer. All opinions expressed by Jim Kramer on this podcast are solely Kramer's opinions and do not reflect the opinions of CNBC or its parent company or affiliates and may have been previously disseminated by Kramer on television, radio, internet or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Kramer's opinions are based upon information he considers reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy and it should not be relied upon as such. To view the full Mad Money Disclaimer please visit CNBC.com forward slash Mad Money Disclaimer.

48:31Whatever, I'm easy.